Clinical Trial Update: Crossover Study to Assess the Efficacy of PT003 With and Without a Valved Holding Chamber in Subjects With Moderate to Severe COPD [Phase 3]

View source ↗

Summary

Phase 3 crossover study evaluating PT003 with and without a valved holding chamber in adults with moderate to severe chronic obstructive pulmonary disease. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• PT003

Snippet

Sponsor: Pearl Therapeutics, Inc. | Conditions: COPD | Phase 3 | Status: COMPLETED | Results posted: 2017-04-19